NEXGEL, Inc. (NXGL)
NCM · Healthcare · Medical Instruments & Supplies
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 2.9M | 2.9M | 2.8M | 2.6M |
| Gross Profit | 1.3M | 1.2M | 819K | 1.1M |
| Operating Income | -636K | -725K | -1.2M | -958K |
| Net Income | -665K | -653K | -970K | -927K |
| Diluted EPS | $-0.09 | $-0.08 | $nan | $-0.11 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 2.0M | 4.1M | 8.7M | 11.4M |
| Gross Profit | 256K | 374K | 2.7M | 4.5M |
| Operating Income | -3.3M | -3.5M | -3.6M | -3.4M |
| Net Income | -4.7M | -3.2M | -3.3M | -3.0M |
| Diluted EPS | $-0.85 | $-0.56 | $-0.50 | $-0.38 |